Systemic delivery of axitinib with nanohybrid liposomal nanoparticles inhibits hypoxic tumor growth-Reference-Cited by-同舟云学术

Systemic delivery of axitinib with nanohybrid liposomal nanoparticles inhibits hypoxic tumor growth

Published:2015 Issue:3 Volume:3 Page:408-416
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Choi Ju Yeon¹²³⁴,Ramasamy Thiruganesh¹²³⁴,Tran Tuan Hiep¹²³⁴,Ku Sae Kwang⁵⁶⁷⁴,Shin Beom Soo¹⁸⁹¹⁰,Choi Han-Gon¹¹¹¹²¹³⁴,Yong Chul Soon¹²³⁴,Kim Jong Oh¹²³⁴

Affiliation:

1. College of Pharmacy

2. Yeungnam University

3. Gyeongsan 712-749

4. Republic of Korea

5. College of Korean Medicine

6. Daegu Haany University

7. Daegu 712-715

8. Catholic University of Daegu

9. Gyeongsan

10. South Korea

11. Institute of Pharmaceutical Science and Technology

12. Hanyang University

13. Ansan 426-791

Abstract

Hybrid liposomal nanoparticles for systemic delivery of axitinib inhibit hypoxic tumor growth.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2015/TB/C4TB01442A

Reference44 articles.

1. Dissemination and growth of cancer cells in metastatic sites

2. What Is the Evidence That Tumors Are Angiogenesis Dependent?

3. VEGF Receptor Signaling in Tumor Angiogenesis

4. iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Injectable dual thermoreversible hydrogel for sustained intramuscular drug delivery;Journal of Controlled Release;2024-10

2. Co-delivery of paclitaxel and curcumin loaded solid lipid nanoparticles for improved targeting of lung cancer: In vitro and in vivo investigation;Heliyon;2024-05

3. Overcoming biological barriers BBB/BBTB by designing PUFA functionalised lipid-based nanocarriers for glioblastoma targeted therapy;Biomaterials Advances;2023-12

4. Insights into Lipid-Based Delivery Nanosystems of Protein-Tyrosine Kinase Inhibitors for Cancer Therapy;Pharmaceutics;2022-12-03

5. Polymer-Based Hybrid Nanoarchitectures for Cancer Therapy Applications;Polymers;2022-07-26